Pathways Knowlegdes

Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit


Pathway DOIs Note
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Accession ID: PathBank:SMP0000373
-
21-Hydroxylase Deficiency (CYP21)

Accession ID: PathBank:SMP0000576
-
3-beta-Hydroxysteroid Dehydrogenase Deficiency

Accession ID: PathBank:SMP0000718
-
Steroidogenesis

Accession ID: PathBank:SMP0087238
-
17-alpha-Hydroxylase Deficiency (CYP17)

Accession ID: PathBank:SMP0120849
-
Corticosterone Methyl Oxidase II Deficiency (CMO II)

Accession ID: PathBank:SMP0120861
-
3-beta-Hydroxysteroid Dehydrogenase Deficiency

Accession ID: PathBank:SMP0120869
-
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency

Accession ID: PathBank:SMP0120451
-
21-Hydroxylase Deficiency (CYP21)

Accession ID: PathBank:SMP0120640
-
11-beta-Hydroxylase Deficiency (CYP11B1)

Accession ID: PathBank:SMP0000575
-
Apparent Mineralocorticoid Excess Syndrome

Accession ID: PathBank:SMP0000717
-
Steroidogenesis

Accession ID: PathBank:SMP0063672
-
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency

Accession ID: PathBank:SMP0120672
-
Corticosterone Methyl Oxidase I Deficiency (CMO I)

Accession ID: PathBank:SMP0120860
-
Apparent Mineralocorticoid Excess Syndrome

Accession ID: PathBank:SMP0120868
-
17-alpha-Hydroxylase Deficiency (CYP17)

Accession ID: PathBank:SMP0120630
-
Corticosterone Methyl Oxidase II Deficiency (CMO II)

Accession ID: PathBank:SMP0120642
-
3-beta-Hydroxysteroid Dehydrogenase Deficiency

Accession ID: PathBank:SMP0120650
-
Steroidogenesis

Accession ID: PathBank:SMP0000130
-
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH

Accession ID: PathBank:SMP0000371
-